Publications by authors named "Mandel R Sher"

Claim this Profile
C
Content validity of the Leicester Cough Questionnaire in adults with refractory or unexplained chronic cough: a qualitative interview study.
Allison Martin Nguyen, Carmen La Rosa, Alexandra G Cornell, Mandel R Sher, Jonathan A Bernstein

Ther Adv Respir Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of US Medicare Beneficiaries with Chronic Cough vs. Non-Chronic Cough: 2011-2018.
Seonkyeong Yang, Shu Huang, Juan M Hincapie-Castillo, Xuehua Ke, Helen Ding, Mandel R Sher

J Clin Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported experiences with refractory or unexplained chronic cough: a qualitative analysis.
Vishal Bali, Jonathan Schelfhout, Mandel R Sher, Anju Tripathi Peters, Gayatri B Patel

Ther Adv Respir Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of Cough Medication Prescribing among Patients with Chronic Cough in Florida: 2012-2021.
Seonkyeong Yang, Shu Huang, Juan M Hincapie-Castillo, Xuehua Ke, Helen Ding, Mandel R Sher

J Clin Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study.
Peter V Dicpinigaitis, Alyn H Morice, Jaclyn A Smith, Mandel R Sher, Michael Vaezi

Lung· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Cough Medication Use Patterns in Ambulatory Care Settings in the United States: 2003-2018.
Seonkyeong Yang, Juan M Hincapie-Castillo, Xuehua Ke, Jonathan Schelfhout, Helen Ding, Mandel R Sher

J Clin Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant.
Alyn H Morice, Surinder S Birring, Jaclyn A Smith, Lorcan P McGarvey, Jonathan Schelfhout, Mandel R Sher

Lung· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial.
Jaclyn A Smith, Michael M Kitt, Alyn H Morice, Surinder S Birring, Lorcan P McGarvey, Mandel R Sher

Lancet Respir Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefapixant in two randomised dose-escalation studies in chronic cough.
Jaclyn A Smith, Michael M Kitt, Peter Butera, Steven A Smith, Yuping Li, Mandel R Sher

Eur Respir J· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective use of 20% subcutaneous immunoglobulin therapy in a man with preexisting thrombi.
Carla Duff, Mandel R Sher, Jennifer W Leiding

Ann Allergy Asthma Immunol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis